Michael Roggelin, APRN
Adult Health · Tampa, FLNPI 1528520756
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (47.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Viiv Healthcare Company accounts for 72.4% of it on its own, with 22 other manufacturers making up the rest. Among adult health clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 444 payments — averaging $46.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$15K
- Gilead$3K
- Theratechnologies Inc.$721
- AbbVie$671
- Merck$546
- Napo Pharmaceuticals Inc$274
- plus $905 from 17 others
What the payments were for
- Speaking & faculty fees$9,76947%
- Travel & lodging$1,4157%
- Food & beverage$9,33645%
- Education$1101%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 179 | $14,930 |
| Gilead | 126 | $2,583 |
| Theratechnologies Inc. | 29 | $721 |
| AbbVie | 28 | $671 |
| Merck | 26 | $546 |
| Napo Pharmaceuticals Inc | 13 | $274 |
| Johnson & Johnson(2 entities) | 13 | $216 |
| EMD Serono, Inc. | 8 | $154 |
| Janssen Products, LP | 1 | $99 |
| Antares Pharma, Inc. | 2 | $67 |
| Tolmar, Inc. | 3 | $55 |
| Bayer | 2 | $51 |
| Exact Sciences | 2 | $39 |
| Janssen Scientific Affairs, LLC | 2 | $35 |
| Verity Pharmaceuticals Inc. | 1 | $34 |
| Acerus Pharmaceuticals Corporation | 2 | $27 |
| GSK | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $19 |
| Phadia US Inc. | 1 | $19 |
| AstraZeneca | 1 | $15 |
| Amgen | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$20,629 in reported general payments places this provider in the 95th percentile of 2,237 adult health providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 63 | $256,583 |
| DescovyEmtricitabine/Tenofov Alafenam | 61 | $131,366 |
| DovatoDolutegravir Sodium/Lamivudine | 43 | $126,363 |
| JulucaDolutegravir/Rilpivirine | 35 | $121,706 |
| CabenuvaCabotegravir/Rilpivirine | 18 | $117,577 |
| SymtuzaDarunavir/Cob/Emtri/Tenof Alaf | 11 | $54,455 |
| TivicayDolutegravir Sodium | 21 | $45,449 |
| TriumeqAbacavir/Dolutegravir/Lamivudi | 11 | $40,626 |
| PifeltroDoravirine | 11 | $18,194 |
| OzempicSemaglutide | 11 | $11,072 |
| EliquisApixaban | 11 | $5,937 |
| Icosapent Ethyl | 11 | $1,355 |
| Pitavastatin Calcium | 12 | $1,077 |
| Doxycycline Monohydrate | 22 | $669 |
| Lamivudine HbvLamivudine | 11 | $623 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Viiv Healthcare CompanyDovato, Juluca, Cabenuva, Tivicay, Triumeq | $14,930 | $451,721128 claims |
| GileadBiktarvy, Descovy | $2,583 | $387,949124 claims |
| Janssen Products, LPSymtuza | $99 | $54,45511 claims |
| MerckPifeltro | $546 | $18,19411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,237 adult health providers in Florida.
Other adult health in Tampa
- Jamie JohnsonTampa$58K
- Jennifer GodshallTampa$29K
- Mercedes FernandezTampa$19K
- Cashawna SchlossnagleTampa$18K
- Jennifer BishopTampa$17K
- Meredith ButlerTampa$16K
- Kimberly RandolphTampa$14K
- Esmeralda YoungTampa$14K
- Peggy WallaceTampa$12K
- Sarah KossiverTampa$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.